A NEW ERA OF REGULATORY CONNECTIVITY
Connect.
Communicate.
Collaborate.
The Accumulus platform is your modern solution for regulatory interactions. It’s one platform for real-time information exchange and new ways of working.
Supported by
The Stakes Are High
Marked by long timelines and high costs, developing a new therapy can take over a decade from discovery to market.
13 Years
Average time from initial discovery through regulatory approval for one new drug.
2 Million
Average number of pages of paper for one new drug application (the pile would be 200 meters tall).
$2 Billion
Average spend from initial discovery to regulatory approval to bring one new drug to market1.
“It’s time for more sustainable and scalable collaboration and information exchange between life sciences organizations and national regulatory authorities. Filing a New Drug Application may have shifted from driving a truckload of paper to the relevant regulatory authority, to FedEx-ing a CD-ROM, to uploading a set of PDFs for submission, but the underlying processes remain little changed. It’s long past time to play catch-up.”
Francisco Nogueira
Chief Executive Officer, at Accumulus Synergy
Nurturing growth: measuring the return from pharmaceutical innovation 2023. Deloitte. Available here
we are here to help you:
Reduce complexity.
Increase security.
Accelerate outcomes.
Accumulus Synergy offers the first fit-for-purpose regulatory collaboration and information exchange platform, transforming how information flows.
Instead of static documents, think instant communication, real-time data exchange, and dynamic insights.
WHY ACCUMULUS
Your Needs Simplified
Optimize Collaboration
Navigate the complexities of regulatory pathways (e.g., Reliance) with ease through automated processes, milestone tracking, notifications, and more.
Enhance Partnerships
Unlock the full potential of your internal and external partnerships by connecting, communicating, and collaborating in a common space to simplify coordination and accelerate innovation.
Improve Security
Define who can view, edit, and share specific documents, ensuring that only authorized personnel have access to critical information.
Adopting the Accumulus platform is not just a technical upgrade; it’s a strategic necessity to keep regulatory interactions on pace with 21st century medicine.
How it works
1. Subscribe today
2. Experience new ways of working tomorrow
Avoid typical frustrations and delays with traditional platforms. With the Accumulus platform you get:
A quick start: get your entire team up and running in as little as just one hour
Seamless onboarding: minimal set-up required- no complex installations or lengthy configuration
A user-friendly interface: intuitive design ensures that your team can start using the platform with minimal training
Instant access*: cloud-based means accessible anytime, anywhere with internet connection
Dedicated support: expert support team available to help you every step of the way
*Subject to the terms of Accumulus' Service Level Agreements (SLAs)
“...streamlining the regulatory approval process across 48 countries holds immense promise. This advancement could potentially expedite access to cutting-edge medicines by nearly two years…”
Roche
Senior Vice President at Roche
LEARN MORE
A New Era of Regulatory Connectivity
Discover how the Accumulus platform can transform your regulatory interactions. Our overview highlights key features, benefits, and real-world applications that make the Accumulus platform an essential tool for your organization. Get the insights you need to make an informed decision—download now!
Complete the form to access your free PDF.
Get free PDF
"*" indicates required fields
Related Resources
Accumulus Responds to Draft Pharmaceutical Quality/Chemistry Manufacturing and Controls
Accumulus Synergy Responds to FDA’s Customer Experience Strategy for Fiscal Years 2024 to 2027
Accumulus Comments to the Food and Drug Administration (FDA) on the development of the Data and Technology Strategic Plan
Accumulus Synergy Responds to FDA’s Draft Pharmaceutical Quality/Chemistry Manufacturing and Controls (PQ/CMC) Data Exchange
Accumulus Synergy Responds Food and Drug Administration’s Information Technology Strategy
